lipid-conjugated siRNA therapeutic (DTx Pharma)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namelipid-conjugated siRNA therapeutic (DTx Pharma)
Drug Alias NameRHO siRNA therapy (DTx Pharma)
ClassificationSmall molecules > LipidSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionRHO gene transference
TargetsRhodopsin
Therapy Area/IndicationsRetinitis Pigmentosa
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDTx Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDTx Pharma Inc
Active IndicationsN/A
Inactive IndicationsRetinitis Pigmentosa

Other Information

ATC CodeN/A
Related LinksN/A